Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment

NCT: NCT07187297 · RECRUITING

NCT IDNCT07187297
StatusRECRUITING
Start Date2025-10-31
Completion2027-03
SponsorBausch Health Americas, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, 180-day, randomized, multicenter, independent blinded evaluators, controlled study of treatment with the Thermage FLX System

Frequently Asked Questions

What is A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment?

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment is a clinical trial registered under NCT07187297. Current status: RECRUITING.

What is the status of NCT07187297?

The current status of NCT07187297 (A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment) is: RECRUITING.

When did A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment start?

A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment started on 2025-10-31.

Related Devices

K190342BIAFINE Topical CreamBausch Health Americas Incorporated

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑